Lutein Induces Reactive Oxygen Species-Mediated Apoptosis in Gastric Cancer AGS Cells via NADPH Oxidase Activation

Ju Won Eom1, Joo Weon Lim1, Hyeyoung Kim1

  • 1Department of Food and Nutrition, College of Human Ecology, Yonsei University, Seoul 03722, Republic of Korea.

Insights

Lutein boosts reactive oxygen species (ROS) production in gastric cancer cells by activating NADPH oxidase. This process triggers apoptosis, offering a potential therapeutic strategy for gastric cancer treatment.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Apoptosis disruption drives cancer progression, making it a key target for anticancer therapies.
  • Reactive oxygen species (ROS) are crucial inducers of apoptosis, activating caspases and leading to DNA fragmentation.
  • Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is a significant endogenous source of ROS involved in apoptosis.

Purpose of the Study:

  • To investigate if lutein activates NADPH oxidase to generate ROS and induce apoptosis in gastric cancer AGS cells.
  • To elucidate the molecular mechanisms underlying lutein's anticancer effects in gastric cancer.

Main Methods:

  • Assessed ROS levels and NADPH oxidase activation in AGS cells treated with lutein.
  • Examined the translocation of NADPH oxidase subunit p47phox, NF-κB activation, and apoptotic markers (Bax, caspase-3 cleavage, DNA fragmentation, Bcl-2).
  • Utilized a specific NADPH oxidase inhibitor (ML171) and an antioxidant (N-acetyl cysteine) to validate lutein's mechanism.

Main Results:

  • Lutein significantly increased ROS levels and activated NADPH oxidase by promoting p47phox translocation.
  • Lutein enhanced NF-κB activation, increased apoptotic indices (Bax, caspase-3 cleavage, DNA fragmentation), and decreased Bcl-2 expression and cell viability.
  • Inhibition of NADPH oxidase or ROS scavenging reversed lutein-induced apoptosis and NF-κB activity.

Conclusions:

  • Lutein-induced ROS production in gastric cancer cells is mediated by NADPH oxidase activation.
  • This ROS production activates NF-κB signaling, leading to apoptosis.
  • Lutein demonstrates potential as a therapeutic agent for enhancing ROS-mediated apoptosis in gastric cancer.